351 related articles for article (PubMed ID: 13677264)
1. Innovative strategies in lymphoma therapy.
Jäger U
Wien Klin Wochenschr; 2003 Aug; 115(13-14):462-70. PubMed ID: 13677264
[TBL] [Abstract][Full Text] [Related]
2. [Recent progress in rituximab therapy and its resistance--how do we overcome?].
Hatake K; Yokoyama M; Terui Y
Gan To Kagaku Ryoho; 2007 Aug; 34(8):1177-82. PubMed ID: 17687198
[TBL] [Abstract][Full Text] [Related]
3. A phase 1 dose escalation study of bortezomib combined with rituximab, cyclophosphamide, doxorubicin, modified vincristine, and prednisone for untreated follicular lymphoma and other low-grade B-cell lymphomas.
Sinha R; Kaufman JL; Khoury HJ; King N; Shenoy PJ; Lewis C; Bumpers K; Hutchison-Rzepka A; Tighiouart M; Heffner LT; Lechowicz MJ; Lonial S; Flowers CR
Cancer; 2012 Jul; 118(14):3538-48. PubMed ID: 22535574
[TBL] [Abstract][Full Text] [Related]
4. Overview of rational and individualized therapeutic strategies for non-Hodgkin's lymphomas.
Armitage JO
Clin Lymphoma; 2002 Dec; 3 Suppl 1():S5-11. PubMed ID: 12521383
[TBL] [Abstract][Full Text] [Related]
5. Hematologic malignancies: new developments and future treatments.
Cheson BD
Semin Oncol; 2002 Aug; 29(4 Suppl 13):33-45. PubMed ID: 12170431
[TBL] [Abstract][Full Text] [Related]
6. Focus on lymphomas.
Staudt LM; Wilson WH
Cancer Cell; 2002 Nov; 2(5):363-6. PubMed ID: 12450791
[No Abstract] [Full Text] [Related]
7. [Monoclonal antibody treatment of malignant lymphoma].
Buske C; Dreyling M; Unterhalt M; Hiddemann W
Internist (Berl); 2004 Dec; 45(12):1370-7. PubMed ID: 15517123
[TBL] [Abstract][Full Text] [Related]
8. Fludarabine combination therapy for the treatment of chronic lymphocytic leukemia.
Schmitt B; Wendtner CM; Bergmann M; Busch R; Franke A; Pasold R; Schlag R; Hopfinger G; Hiddemann W; Emmerich B; Hallek M
Clin Lymphoma; 2002 Jun; 3(1):26-35. PubMed ID: 12141952
[TBL] [Abstract][Full Text] [Related]
9. Effective immunochemotherapy for aggressive non-Hodgkin's lymphoma.
Coiffier B
Semin Oncol; 2004 Feb; 31(1 Suppl 2):7-11. PubMed ID: 15042528
[TBL] [Abstract][Full Text] [Related]
10. Classification updates and clinical investigations in indolent non-Hodgkin lymphoma.
Cheson BD
Clin Adv Hematol Oncol; 2008 Sep; 6(9):4-6. PubMed ID: 18998258
[No Abstract] [Full Text] [Related]
11. New concepts in treatment approaches and prognostic factors in aggressive NHL.
Shipp M
Clin Adv Hematol Oncol; 2006 Feb; 4(2):107-9. PubMed ID: 16728917
[No Abstract] [Full Text] [Related]
12. [Promising targeted molecular therapies for the future years in non-small-cell lung cancer].
Soria JC
Rev Pneumol Clin; 2006 Feb; 62 Spec no 1():1S35-6. PubMed ID: 16719155
[No Abstract] [Full Text] [Related]
13. 6th European Hematology Association Meeting. Frankfurt, Germany. June 21-24, 2001.
Maung K; D'Orazio AI
Clin Lymphoma; 2001 Sep; 2(2):74-9. PubMed ID: 11712544
[No Abstract] [Full Text] [Related]
14. Diffuse aggressive lymphoma.
Fisher RI; Miller TP; O'Connor OA
Hematology Am Soc Hematol Educ Program; 2004; ():221-36. PubMed ID: 15561685
[TBL] [Abstract][Full Text] [Related]
15. [Treatment options in non-Hodgkin lymphomas].
Tilly H
Rev Prat; 2010 Jan; 60(1):69-74. PubMed ID: 20222315
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal antibody therapy for lymphoma.
Campbell P; Marcus R
Blood Rev; 2003 Sep; 17(3):143-52. PubMed ID: 12818224
[TBL] [Abstract][Full Text] [Related]
17. Antibody therapy in non-Hodgkin's lymphoma: the role of rituximab, 90Y-ibritumomab tiuxetan, and alemtuzumab.
Fietz T; Thiel E
Recent Results Cancer Res; 2007; 176():153-63. PubMed ID: 17607923
[TBL] [Abstract][Full Text] [Related]
18. Chemotherapy combinations with monoclonal antibodies in non-Hodgkin's lymphoma.
Kahl B
Semin Hematol; 2008 Apr; 45(2):90-4. PubMed ID: 18381103
[TBL] [Abstract][Full Text] [Related]
19. Targeting the proapoptotic factor Bcl-2 in non-Hodgkin's lymphoma.
Klasa RJ
Oncology (Williston Park); 2004 Nov; 18(13 Suppl 10):25-31. PubMed ID: 15651174
[TBL] [Abstract][Full Text] [Related]
20. Antibody therapy of lymphoma.
Illidge TM; Bayne MC
Expert Opin Pharmacother; 2001 Jun; 2(6):953-61. PubMed ID: 11585011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
